0 items USD 0.00Search
Your search for "qyresearch china biosimilar monoclonal antibodies industry 2016 market research report" gave back 49887 results.
The global Adalimumab Monoclonal Antibody Biosimilar market size was valued at USD 433.2 million in 2022 and is forecast to a readjusted size of USD...
Catalog:
GIR
June 2023
Price: USD 3,480.00
The global Bevacizumab Monoclonal Antibody Biosimilar market size was valued at USD 1379.8 million in 2022 and is forecast to a readjusted size of...
Catalog:
GIR
June 2023
Price: USD 3,480.00
Monoclonal antibodies (mAb) are antibodies produced by using identical immune cells that are clones of one unique parent cell. Since monoclonal...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
The global Biosimilar Antibodies market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a...
Catalog:
GIR
March 2024
Price: USD 3,480.00
Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones,...
Catalog:
GIR
September 2024
Price: USD 3,480.00
The global Biosimilar market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %...
Catalog:
GIR
January 2024
Price: USD 3,480.00
The global Biosimilar Antibodies market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (...
Catalog:
GIR
March 2024
Price: USD 4,480.00
The global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Global monoclonal antibodies market will reach $329.6 billion by 2030, growing by 10.9% annually over 2020-2030, driven by the increasing incidences...
Catalog:
Grace Market Data
December 2021
Price: USD 3,200.00
The global Biosimilar market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar is forecast to a...
Catalog:
LPI
January 2024
Price: USD 3,660.00
The global Biosimilar and Biologics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a...
Catalog:
GIR
March 2024
Price: USD 3,480.00
The global Trastuzumab Monoclonal Antibody market size is expected to reach $ 6357.7 million by 2029, rising at a market growth of 4.6% CAGR during...
Catalog:
GIR
June 2023
Price: USD 4,480.00
The global Trastuzumab Monoclonal Antibody market size is projected to grow from US$ 4413.9 million in 2022 to US$ 6202.2 million in 2029; it is...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Biologics and Biosimilars market size is projected to grow from US$ 458090 million in 2022 to US$ 838760 million in 2029; it is expected...
Catalog:
LPI
May 2023
Price: USD 3,660.00
The global Rituxan (Rituximab) Monoclonal Antibody market size is projected to grow from US$ 4035.3 million in 2022 to US$ 5179.6 million in 2029; it...
Catalog:
LPI
June 2023
Price: USD 3,660.00
